Maintenance fees coming due
84 maintenance fees come due in the 12 months from Nov 15, 2026, the next on Nov 16, 2026. Unpaid by May 17, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,649,461 | Polynucleotides Encoding Alpha-Galactosidase a for the Treatment of Fabry Disease In force Fee due Nov 16, 2026 Lapses if unpaid May 17, 2027 · High confidence | ModernaTX, Inc. | In force | Nov 16, 2026 | May 17, 2027 | High confidence | |
| US 11,660,341 | Mrna Combination Therapy for the Treatment of Cancer In force Fee due Nov 30, 2026 Lapses if unpaid Jun 1, 2027 · High confidence | ModernaTX, Inc. | In force | Nov 30, 2026 | Jun 1, 2027 | High confidence | |
| US 9,050,297 | Modified Polynucleotides Encoding Aryl Hydrocarbon Receptor Nuclear Translocator In force Fee due Dec 9, 2026 Lapses if unpaid Jun 9, 2027 · High confidence | ModernaTX, Inc. | In force | Dec 9, 2026 | Jun 9, 2027 | High confidence | |
| US 10,322,090 | Combinations of Mrnas Encoding Immune Modulating Polypeptides and Uses Thereof In force Fee due Dec 18, 2026 Lapses if unpaid Jun 21, 2027 · High confidence | ModernaTX, Inc. | In force | Dec 18, 2026 | Jun 21, 2027 | High confidence | |
| US 10,322,091 | Combinations of Mrnas Encoding Immune Modulating Polypeptides and Uses Thereof In force Fee due Dec 18, 2026 Lapses if unpaid Jun 21, 2027 · High confidence | ModernaTX, Inc. | In force | Dec 18, 2026 | Jun 21, 2027 | High confidence | |
| US 10,323,076 | Polynucleotides Encoding Low Density Lipoprotein Receptor In force Fee due Dec 18, 2026 Lapses if unpaid Jun 21, 2027 · High confidence | ModernaTX, Inc. | In force | Dec 18, 2026 | Jun 21, 2027 | High confidence | |
| US 9,061,059 | Modified Polynucleotides for Treating Protein Deficiency In force Fee due Dec 23, 2026 Lapses if unpaid Jun 23, 2027 · High confidence | ModernaTX, Inc. | In force | Dec 23, 2026 | Jun 23, 2027 | High confidence | |
| US 11,687,256 | Methods of Using OX40 Ligand Encoding Polynucleotides In force Fee due Dec 27, 2026 Lapses if unpaid Jun 28, 2027 · High confidence | ModernaTX, Inc. | In force | Dec 27, 2026 | Jun 28, 2027 | High confidence | |
| US 10,335,486 | Mrna Combination Therapy for the Treatment of Cancer In force Fee due Jan 2, 2027 Lapses if unpaid Jul 2, 2027 · High confidence | ModernaTX, Inc. | In force | Jan 2, 2027 | Jul 2, 2027 | High confidence | |
| US 11,696,892 | Lipid Nanoparticles for Delivering Modified RNA Encoding a VEGF-A Polypeptide In force Fee due Jan 11, 2027 Lapses if unpaid Jul 12, 2027 · High confidence | ModernaTX, Inc. | In force | Jan 11, 2027 | Jul 12, 2027 | High confidence | |
| 74 more maintenance fees coming due in the 12 months from Nov 15, 2026 · Pro | |||||||
10 of 84 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.